Michelle M. O’Shaughnessy

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri et al. · Kidney International · 2016 · 674 citations · Full text

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Jürgen Floege, Sean Barbour, Daniel Cattran et al. · Kidney International · 2019 · 257 citations · Full text

C3 Glomerulopathy

Nicholas Medjeral‐Thomas, Michelle M. O’Shaughnessy, John O’Regan et al. · Clinical Journal of the American Society of Nephrology · 2013 · 243 citations · Full text

Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey

Michelle M. O’Shaughnessy, Susan L. Hogan, Bawana D. Thompson et al. · Nephrology Dialysis Transplantation · 2017 · 228 citations · Full text

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text